Alerts will be sent to your verified email
Verify Email
FISCHER
|
Fischer Medical
|
Neogen Chemicals
|
Fineotex Chemical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.29 % | 9.35 % | 21.66 % |
|
5yr average Equity Multiplier
|
0.49 | 2.16 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 0.57 | 0.96 |
|
5yr Avg Net Profit Margin
|
-4.14 % | 7.08 % | 18.58 % |
|
Price to Book
|
8.14 | 3.62 | 3.63 |
|
P/E
|
147.14 | 111.23 | 28.75 |
|
5yr Avg Cash Conversion Cycle
|
140.14 Days | 98.08 Days | 50.7 Days |
|
Inventory Days
|
33.45 Days | 139.02 Days | 38.72 Days |
|
Days Receivable
|
163.11 Days | 112.52 Days | 87.15 Days |
|
Days Payable
|
23.17 Days | 128.64 Days | 72.34 Days |
|
5yr Average Interest Coverage Ratio
|
12.88 | 3.19 | 110.39 |
|
5yr Avg ROCE
|
3.71 % | 13.63 % | 27.86 % |
|
5yr Avg Operating Profit Margin
|
6.78 % | 17.33 % | 21.92 % |
|
5 yr average Debt to Equity
|
-0.66 | 0.74 | 0.01 |
|
5yr CAGR Net Profit
|
n/a | 2.14 % | 20.5 % |
|
5yr Average Return on Assets
|
-4.27 % | 4.22 % | 17.65 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.8 % | 51.23 % | 62.88 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
61.8 % | -8.96 % | -2.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 4.81 % | -2.38 % |
|
Fischer Medical
|
Neogen Chemicals
|
Fineotex Chemical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|